Novo Nordisk Pre-Tax Income 2010-2024 | NVO

Novo Nordisk pre-tax income for the twelve months ending June 30, 2024 was $16.393B, a 39.12% increase year-over-year.

  • Novo Nordisk annual pre-tax income for 2023 was $15.199B, a 55.42% increase from 2022.
  • Novo Nordisk annual pre-tax income for 2022 was $9.779B, a 4.04% increase from 2021.
  • Novo Nordisk annual pre-tax income for 2021 was $9.4B, a 15.48% increase from 2020.

Novo Nordisk Pre-Tax Income 2010-2024 | NVO

  • Novo Nordisk annual pre-tax income for 2023 was $15.199B, a 55.42% increase from 2022.
  • Novo Nordisk annual pre-tax income for 2022 was $9.779B, a 4.04% increase from 2021.
  • Novo Nordisk annual pre-tax income for 2021 was $9.4B, a 15.48% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M